Voluntary Disclosure on the Approval of Clinical Trial for Recombinant Polio Vaccine in Indonesia

About this update from Cansino Biologics, Inc. Class A

Voluntary Disclosure on the Approval of Clinical Trial for Recombinant Polio Vaccine in IndonesiaThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Cansino Biologics, Inc. Class A